• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于 2 型糖尿病患者持续皮下胰岛素输注与多次皮下注射胰岛素治疗的系统评价和荟萃分析。

A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes.

机构信息

Department of Orthopedics, General Hospital "Ippokrateion", Konstantinoupoleos 49, 54642 Thessaloniki, Greece.

Choremeio Research Laboratory, First Department of Pediatrics, National and Kapodistrian University of Athens, Thivon & Levadeias 8, 11527 Athens, Greece.

出版信息

Medicina (Kaunas). 2023 Jan 10;59(1):141. doi: 10.3390/medicina59010141.

DOI:10.3390/medicina59010141
PMID:36676765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9861993/
Abstract

Diabetes mellitus (DM) has a growing prevalence worldwide, even in developing countries. Many antidiabetic agents are used to improve glycemic control; however, in cases of an insufficient outcome, insulin is administered. Yet, the timing of proper insulin administration is still a subject of intense research. To date, there have been no recommendations or guidelines for the use of continuous subcutaneous insulin infusion (CSII) in Type 2 Diabetes Mellitus (T2DM). In the present study, we have performed a meta-analysis to evaluate the use of CSII in patients with T2DM. An extensive literature search was conducted through the electronic databases Pubmed, Clinicaltrials.gov, and Cochrane Central Register of Controlled Trials (CENTRAL) from October 2019-May 2022, for interventional studies related to T2DMI and CSII versus multiple daily injections (MDI). We included articles published in the English language only, yielding a total of thirteen studies. We found better outcomes in patients receiving CSII, in regard to glycated hemoglobin (HbA1c) and total insulin dose. In contrast, fasting plasma glucose and body weight did not show statistically significant differences between the two groups. Our analyses showed that CSII could be beneficial in patients with T2DM in order to achieve their glucose targets.

摘要

糖尿病(DM)在全球范围内的患病率不断上升,甚至在发展中国家也是如此。许多抗糖尿病药物被用于改善血糖控制;然而,在疗效不佳的情况下,会给予胰岛素。然而,适当给予胰岛素的时机仍然是一个研究热点。迄今为止,对于 2 型糖尿病(T2DM)患者使用持续皮下胰岛素输注(CSII)尚未有任何建议或指南。在本研究中,我们进行了一项荟萃分析,以评估 CSII 在 T2DM 患者中的应用。我们通过电子数据库 Pubmed、Clinicaltrials.gov 和 Cochrane 对照试验中心(CENTRAL),从 2019 年 10 月至 2022 年 5 月进行了广泛的文献检索,以查找与 T2DMI 和 CSII 与多次每日注射(MDI)相关的干预性研究。我们仅纳入了发表在英语中的文章,共纳入了 13 项研究。我们发现接受 CSII 的患者在糖化血红蛋白(HbA1c)和总胰岛素剂量方面有更好的结果。相比之下,两组之间空腹血浆葡萄糖和体重没有显示出统计学上的显著差异。我们的分析表明,CSII 可能对 T2DM 患者有益,以达到他们的血糖目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4414f6b99378/medicina-59-00141-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4e35f99b7d3e/medicina-59-00141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/db320fc7c353/medicina-59-00141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/62fe9e1a18a9/medicina-59-00141-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/644ab5297bbe/medicina-59-00141-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/2d1373366d6e/medicina-59-00141-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/c20095697f48/medicina-59-00141-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/1a36bc7f6eb5/medicina-59-00141-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4effbe24449d/medicina-59-00141-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/c7eb394729cd/medicina-59-00141-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4414f6b99378/medicina-59-00141-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4e35f99b7d3e/medicina-59-00141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/db320fc7c353/medicina-59-00141-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/62fe9e1a18a9/medicina-59-00141-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/644ab5297bbe/medicina-59-00141-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/2d1373366d6e/medicina-59-00141-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/c20095697f48/medicina-59-00141-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/1a36bc7f6eb5/medicina-59-00141-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4effbe24449d/medicina-59-00141-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/c7eb394729cd/medicina-59-00141-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4c9/9861993/4414f6b99378/medicina-59-00141-g010.jpg

相似文献

1
A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes.一项关于 2 型糖尿病患者持续皮下胰岛素输注与多次皮下注射胰岛素治疗的系统评价和荟萃分析。
Medicina (Kaunas). 2023 Jan 10;59(1):141. doi: 10.3390/medicina59010141.
2
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.糖尿病孕妇持续皮下胰岛素输注与多次皮下注射胰岛素的比较
Cochrane Database Syst Rev. 2016 Jun 7;2016(6):CD005542. doi: 10.1002/14651858.CD005542.pub3.
3
Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.糖尿病持续皮下胰岛素输注的临床效果及成本效益
Health Technol Assess. 2004 Oct;8(43):iii, 1-171. doi: 10.3310/hta8430.
4
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.临床有效性和成本效益的连续皮下胰岛素输注治疗糖尿病: 系统评价和经济评估。
Health Technol Assess. 2010 Feb;14(11):iii-iv, xi-xvi, 1-181. doi: 10.3310/hta14110.
5
Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.糖尿病胰岛素给药与血糖监测方法:一项比较有效性综述的总结
J Manag Care Pharm. 2012 Aug;18(6 Suppl):S1-17. doi: 10.18553/jmcp.2012.18.s6-A.1.
6
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.用于管理1型糖尿病患者血糖水平的集成式传感器增强泵治疗系统[美敦力MiniMed® Paradigm™ Veo系统以及Vibe™和G4® PLATINUM连续血糖监测(CGM)系统]:一项系统综述与经济学评估
Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.
7
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.糖尿病患者皮下胰岛素持续输注与多次每日胰岛素注射的比较:系统评价与荟萃分析
Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20.
8
Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.比较糖尿病胰岛素输送和血糖监测方法的有效性和安全性:系统评价和荟萃分析。
Ann Intern Med. 2012 Sep 4;157(5):336-47. doi: 10.7326/0003-4819-157-5-201209040-00508.
9
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.用于治疗肾移植受者中已存在的和新发糖尿病的降糖药物。
Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2.
10
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.持续皮下胰岛素输注与多次皮下注射胰岛素治疗糖尿病孕妇的比较。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD005542. doi: 10.1002/14651858.CD005542.pub2.

引用本文的文献

1
Changes in inflammatory markers and efficacy analysis of continuous subcutaneous insulin infusion in senior patients with type 2 diabetes mellitus hospitalized with community-acquired pneumonia: a randomized controlled trial.老年 2 型糖尿病合并社区获得性肺炎住院患者采用持续皮下胰岛素输注的炎症标志物变化及疗效分析:一项随机对照试验。
Eur Geriatr Med. 2024 Apr;15(2):519-525. doi: 10.1007/s41999-023-00915-6. Epub 2024 Jan 9.

本文引用的文献

1
Continuous Subcutaneous Insulin Infusion (CSII) Combined with Oral Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomized, Controlled Trials.持续皮下胰岛素输注(CSII)联合口服降糖药治疗2型糖尿病:一项随机对照试验的系统评价和网状Meta分析
Pharmaceuticals (Basel). 2022 Jul 30;15(8):953. doi: 10.3390/ph15080953.
2
Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group.将胰高血糖素样肽-1 受体激动剂的心血管结局试验结果转化为临床实践:来自东欧和南欧糖尿病专家组的建议。
Int J Cardiol. 2022 Oct 15;365:8-18. doi: 10.1016/j.ijcard.2022.07.017. Epub 2022 Jul 26.
3
Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK.新型混合闭环系统与连续皮下胰岛素输注在英国 1 型糖尿病患者中的成本效益比较。
J Med Econ. 2021 Jan-Dec;24(1):883-890. doi: 10.1080/13696998.2021.1939706.
4
Technology in the management of type 2 diabetes: Present status and future prospects.技术在 2 型糖尿病管理中的应用:现状与展望。
Diabetes Obes Metab. 2021 Aug;23(8):1722-1732. doi: 10.1111/dom.14418. Epub 2021 May 20.
5
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
6
3. Prevention or Delay of Type 2 Diabetes: .3. 2 型糖尿病的预防或延迟: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S34-S39. doi: 10.2337/dc21-S003.
7
Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump Therapy.预测胰岛素泵治疗 1 型糖尿病患者的个体基础率曲线。
J Diabetes Sci Technol. 2021 Nov;15(6):1273-1281. doi: 10.1177/1932296820972691. Epub 2020 Nov 30.
8
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model.基于模拟模型比较简单胰岛素输注装置与多次每日注射在美国未控制的2型糖尿病患者中的成本效益
J Health Econ Outcomes Res. 2018 Aug 22;6(1):84-95. doi: 10.36469/9789. eCollection 2018.
9
Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies.胰岛素泵治疗 2 型糖尿病患者:证据、当前障碍和新技术。
J Diabetes Sci Technol. 2021 Jul;15(4):901-915. doi: 10.1177/1932296820928100. Epub 2020 Jun 1.
10
Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.成人 2 型糖尿病患者经持续皮下胰岛素输注与多次皮下胰岛素注射给予人常规 U-500 胰岛素:VIVID 研究。
Diabetes Obes Metab. 2020 Mar;22(3):434-441. doi: 10.1111/dom.13947. Epub 2020 Jan 26.